Selank — Synthetic Heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro)

Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin developed by the Institute of Molecular Genetics (Russian Academy of Sciences). Unlike traditional anxiolytics, Selank has been studied for its anxiolytic, cognitive-enhancing (nootropic), immunomodulatory, and neuroprotective effects without typical sedation or dependence. Its unique design allows interaction with multiple central nervous system pathways, including neurotransmitter systems and neurotrophic factor regulation.

Key Mechanisms of Action

1. Neurotransmitter Modulation:
Selank influences key neurotransmitter systems — including GABA, serotonin, dopamine, and noradrenaline — contributing to emotional regulation, mood stability, and cognitive processing. Regenerative Therapy+1

2. GABAergic System Support:
It appears to modulate the GABAergic system indirectly, enhancing inhibitory signaling that supports anxiety reduction without sedation typically associated with benzodiazepines. Polaris Peptides

3. Neurotrophic Factor Regulation:
Preclinical research demonstrates that intranasal Selank increases Brain-Derived Neurotrophic Factor (BDNF) gene expression and protein levels in rodent hippocampus — a mechanism tied to improved neuronal survival, learning, and memory processes. SpringerLink+1

4. Gene Expression Modulation:
Selank administration induces broad changes in hippocampal gene expression related to neurotransmission, neural signaling, and immune processes in animal models, highlighting its multifaceted impact on brain function. Benchchem

Key Evidence

Anxiolytic and Mood Regulation (Human Clinical Data)

• A clinical trial comparing Selank to the benzodiazepine medazepam in patients with generalized anxiety disorder (GAD) and neurasthenia found that Selank produced anxiolytic effects comparable to medazepam and additional improvements in energy and cognitive function. Selank lowered symptom severity on standardized scales. Medical Anti-Aging+1

BDNF and Cognitive Outcomes (Animal Models)

• In rodent models, intranasal Selank increased BDNF mRNA and protein levels in the hippocampus, indicating potential support for neuroplasticity, learning, and memory. SpringerLink

Mechanistic Research (Preclinical and Translational):

• Selank has been shown to modulate neurotransmitter dynamics, influence gene expression in stress-related pathways, and affect immune-related signaling molecules — underscoring broad regulatory potential in neural and immune systems. Benchchem

Potential Clinical Implications

Anxiety and Stress Management:
Selank’s primary researched application is as an anxiolytic agent that reduces anxiety without sedation or cognitive impairment. This positions it as a candidate for managing GAD, stress-related disorders, and emotional dysregulation. Medical Anti-Aging

Cognitive Enhancement:
By modulating BDNF and neurotransmitter systems, Selank shows promise in supporting memory formation, attention, mental clarity, and resilience under stress — functions central to nootropic strategies. SpringerLink

Neuroprotection and Neuroplasticity:
The ability to influence neurotrophic factors and gene expression involved in neural survival and plasticity suggests possible roles in neuroprotective approaches and recovery after neural injury or chronic stress. Benchchem

Neuroimmune Interaction:
Derived from an immunomodulatory peptide, Selank also impacts cytokine profiles and immune signaling pathways that intersect with mental health and stress adaptation. Revive Lab

Safety and Regulatory Notes

• Clinical use of Selank is approved in Russia for anxiety and related conditions but it is not approved by the U.S. FDA; outside specific regions it is classified as a research compound. Regenerative Therapy

• Reported side effects are minimal in controlled settings, with mild local irritation (e.g., nasal) as the most noted reaction in intranasal studies. Regenerative Therapy